Turgut Tatlisumak Selected Research

N(1)-dansylspermine

12/2004

The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Turgut Tatlisumak Research Topics

Disease

82	Stroke (Strokes) 12/2022 - 06/2003
53	Ischemic Stroke 12/2022 - 04/2003
14	Hemorrhage 03/2022 - 06/2007
13	Cerebral Hemorrhage 03/2022 - 04/2007
11	Atrial Fibrillation 01/2021 - 02/2015
9	Thrombosis (Thrombus) 01/2022 - 01/2009
8	Hypertension (High Blood Pressure) 01/2021 - 08/2011
8	Embolic Stroke 01/2020 - 08/2015
7	Hematoma 03/2022 - 04/2007
6	Thrombocytopenia (Thrombopenia) 10/2022 - 01/2021
6	Infarction (Infarctions) 02/2022 - 06/2003
6	Brain Ischemia (Cerebral Ischemia) 10/2021 - 04/2003
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2015 - 12/2004
4	Neoplasms (Cancer) 01/2022 - 08/2010
4	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2022 - 01/2021
4	Diabetes Mellitus 01/2021 - 09/2014
4	Hyperglycemia 08/2017 - 01/2011
4	Ischemia 12/2011 - 04/2003
3	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022 - 04/2013
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2022 - 11/2018
3	Inflammation (Inflammations) 07/2021 - 08/2013
3	Dyslipidemias (Dyslipidemia) 01/2021 - 08/2011
3	Infections 06/2019 - 12/2013
3	Transient Ischemic Attack 01/2019 - 12/2011
3	Embolism (Embolus) 06/2018 - 09/2016
3	Brain Infarction 09/2016 - 01/2009
3	Edema (Dropsy) 10/2013 - 01/2009
3	Brain Edema (Cerebral Edema) 12/2011 - 05/2006
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2009 - 06/2007
2	COVID-19 11/2021 - 01/2021
2	Brain Injuries (Brain Injury) 01/2021 - 01/2009
2	Hemianopsia (Bitemporal Hemianopsia) 01/2021 - 10/2012
2	Atherosclerosis 01/2021 - 12/2019
2	Insulin Resistance 01/2020 - 09/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2018
2	Fibromuscular Dysplasia 06/2019 - 01/2014
2	Blood Vessel Dissection 08/2015 - 09/2007
2	Neck Pain (Cervicalgia) 01/2014 - 04/2010
2	Neoplasm Metastasis (Metastasis) 01/2011 - 08/2010
1	Cerebral Small Vessel Diseases 04/2022
1	Paresis (Hemiparesis) 02/2022

Drug/Important Bio-Agent (IBA)

21	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2003
14	AnticoagulantsIBA 12/2020 - 07/2004
8	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 01/2011
6	Pharmaceutical PreparationsIBA 12/2020 - 04/2003
6	RivaroxabanIBA 01/2020 - 08/2015
6	Blood Glucose (Blood Sugar)IBA 08/2017 - 01/2011
5	ChAdOx1 nCoV-19IBA 01/2022 - 01/2021
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2016
5	Vitamin K FDA Link 01/2020 - 07/2015
5	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 07/2010
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 08/2011
4	Ad26COVS1IBA 01/2022 - 01/2021
4	salicylhydroxamic acid (SHAM)IBA 01/2022 - 12/2004
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 09/2016
4	danaparoid (Orgaran)FDA Link 01/2017 - 04/2009
4	LipidsIBA 09/2014 - 08/2011
3	Biological ProductsIBA 01/2022 - 01/2015
3	COVID-19 VaccinesIBA 01/2022 - 01/2021
3	HDL CholesterolIBA 01/2021 - 09/2012
3	Factor Xa (Coagulation Factor Xa)IBA 01/2020 - 09/2016
3	Factor Xa InhibitorsIBA 06/2018 - 08/2015
3	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 03/2014 - 10/2012
2	Antidepressive Agents (Antidepressants)IBA 12/2022 - 02/2022
2	VaccinesIBA 10/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	fibrin fragment D (D-dimer)IBA 01/2022 - 04/2013
2	mRNA VaccinesIBA 01/2022 - 11/2021
2	Heparin (Liquaemin)FDA LinkGeneric 11/2021 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 12/2011
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 12/2016
2	LDL CholesterolIBA 11/2018 - 09/2012
2	Triglycerides (Triacylglycerol)IBA 11/2018 - 09/2012
2	Dabigatran FDA Link 11/2017 - 08/2015
2	Warfarin (Coumadin)FDA LinkGeneric 12/2016 - 01/2016
2	N(4)-oleylcytosine arabinosideIBA 09/2015 - 08/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2015 - 10/2012
2	2,6-dinitrotoluene (DNT)IBA 05/2015 - 10/2013
2	C-Reactive ProteinIBA 09/2014 - 09/2012
2	Vascular Endothelial Growth Factor CIBA 08/2013 - 04/2011
2	Evans Blue (Blue, Evans)FDA Link 12/2011 - 05/2006
2	AlbuminsIBA 12/2011 - 05/2006
2	p-Methoxy-N-methylphenethylamineIBA 12/2011 - 04/2007
2	Tenecteplase FDA Link 01/2008 - 01/2006
2	Neuroprotective AgentsIBA 12/2004 - 10/2004
1	Tranexamic Acid (AMCA)FDA Link 03/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	FibrinIBA 01/2022

Therapy/Procedure

28	Therapeutics 07/2021 - 10/2004
10	Secondary Prevention 01/2020 - 07/2004
8	Thrombolytic Therapy 01/2021 - 01/2003
7	Thrombectomy 01/2022 - 01/2016
4	Treatment Delay 05/2017 - 10/2013
3	Sutures (Suture) 03/2012 - 09/2005
2	Length of Stay 09/2020 - 01/2009
2	Contraindications 11/2019 - 07/2010
2	Transcranial Magnetic Stimulation 01/2015 - 03/2012
2	Carotid Endarterectomy 09/2011 - 07/2003
1	Glycemic Control 04/2022